Skip to search formSkip to main contentSkip to account menu

Paromomycin Sulfate

Known as: Humycin sulfate, D-Streptamine, O-2-amino-2-deoxy-alpha-D-glucopyranosyl-(1->4)-O-(O-2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl-(1->3)-beta-D-ribofuranosyl-(1->5))-2-deoxy-, Sulfate(salt), Paromomycin Sulfate [Chemical/Ingredient] 
The sulfate salt form of paromomycin, a structural derivative of neomycin, an aminoglycoside antibiotic with amebicidal and bactericidal effects… 
National Institutes of Health

Related topics

Related topics

14 relations
AmebiasisAntibiotics, AminoglycosideAntiprotozoal AgentsCryptosporidiosis

Narrower (2)

GabbromycinHumatin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Effect of topical Nanoliposomes of Paromomycin on Rats Liver and Kidney
Background: Hepatotoxicity due to drugs is the most common cause of deaths. Nephrotoxicity of the drugs is usually associated… 
2013
2013
Effect of in-feed paromomycin supplementation on antimicrobial resistance of enteric bacteria in turkeys.
2011
2011
Combination Therapy with Paromomycin-Associated Stearylamine-Bearing Liposomes Cures Experimental Visceral Leishmaniasis through Th1-Biased Immunomodulation
ABSTRACT Visceral leishmaniasis (VL) caused by the parasite Leishmania donovani is a potentially fatal disease. Available limited… 
Highly Cited
2005
Highly Cited
2005
Comparison of topical paromomycin sulfate (twice/day) with intralesional meglumine antimoniate for the treatment of cutaneous leishmaniasis caused by L. major.
This is an open study to compare the cure rate of cutaneous leishmaniasis caused by L. major and treated with either paromomycin… 
1998
1998
Tratamento da leishmaniose mucosa com sulfato de aminosidine: resultados de dois anos de acompanhamento
In 1996, 20 of 21 patients with mucosal leishmaniasis, treated in 1994 with aminosidine sulfate, 16mg/kg/day salt, by… 
Review
1996
Review
1996
[Comparative study of meglumine antimoniate, pentamidine isethionate and aminosidine sulfate in the treatment of primary skin lesions caused by Leishmania (Viannia) braziliensis].
With the aim of comparing the therapeutic efficacy, tolerability and toxicity of meglumine antimoniate, aminosidine sulphate and… 
1996
1996
[Open therapeutic study with aminosidine sulfate in mucosal leishmaniasis caused by Leishmania (Viannia) braziliensis].
From September to November 1994. 21 patients with active mucosal leishmaniasis were treated with aminosidine sulphate 16 mg/kg… 
1995
1995
Use of paromomycin as a selective agent for oat transformation
SummaryFriable, embryogenic oat (Avena sativa L.) tissue cultures were stably transformed with two different plasmids containing… 
1993
1993
Topical treatment of New World cutaneous leishmaniasis in Belize: a clinical study.
1970
1970
Malabsorption due to paromomycin.
Administration of paromomycin sulfate (2 gm/ day) to seven healthy Thai volunteers resulted in malabsorption of xylose and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)